World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 August 2015
Main ID:  NCT02121171
Date of registration: 19/04/2014
Prospective Registration: No
Primary sponsor: National Centre of Ophthalmology named after academician Zarifa Aliyeva
Public title: Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma
Scientific title: Comparative Evaluation of Combined Trabeculotomy-trabeculectomy Versus Combined Trabeculotomy-trabeculectomy With Subconjunctival Implantation of Collagen Matrix Implant for Primary Congenital Glaucoma.
Date of first enrolment: September 2010
Target sample size: 40
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT02121171
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 1
Countries of recruitment
Azerbaijan
Contacts
Name:     Nigar Makhmudova
Address: 
Telephone:
Email:
Affiliation:  Ophthalmologist at National Centre of Ophthalmology
Key inclusion & exclusion criteria

Inclusion Criteria:

- Any case diagnosed as congenital glaucoma with enlarged corneal diameter more than 11
mm and intra-ocular pressure above 21 mmHg, including corneal edema or Haab's stria
with or without optic disc cupping.

Any case diagnosed as primary or secondary congenital glaucoma to ocular or systemic
abnormalities.

Within the age of (0 - 12).

Exclusion Criteria:

- Cases of congenital glaucoma with previous intervention. Age above 12 Yrs. Cases with
secondary glaucoma caused by surgical intervention, ocular co-morbidity, medications
or trauma



Age minimum: 6 Months
Age maximum: 12 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Congenital Glaucoma
Intervention(s)
Procedure: Combined trabeculotomy-trabeculectomy
Device: Ologen Collagen Matrix
Primary Outcome(s)
Intraocular pressure(IOP) reduction [Time Frame: At postoperative up to 24 months]
Secondary Outcome(s)
Postoperative complications and appearances. [Time Frame: At postoperative up to 24 months.]
Secondary ID(s)
Trab+Trab+Ologen
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Aeon Astron Europe B.V.
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history